Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/23425Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.advisor | Iorio, Alfonso | - |
| dc.contributor.author | Mussa, Joseph | - |
| dc.date.accessioned | 2018-10-22T15:02:32Z | - |
| dc.date.available | 2018-10-22T15:02:32Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.uri | http://hdl.handle.net/11375/23425 | - |
| dc.description.abstract | A design pilot study proposed as a Canadian, multicenter, open-label, randomized waitlist clinical trial over the duration of six months to determine the success of running a full-scale RCT with the newly designed WAPPS-Hemo calculator in the Canadian Hemophilia community. The WAPPS-Hemo calculator is widely viewed as a beneficial tool to clinicians and patients and has the potential to optimize and tailor the prophylaxis regimen for hemophilia patients. | en_US |
| dc.language.iso | en | en_US |
| dc.subject | hemophilia | en_US |
| dc.subject | wapps-hemo | en_US |
| dc.subject | prophylaxis | en_US |
| dc.title | A RANDOMIZED WAIT-LIST, PILOT DESIGN THESIS: Feasibility of the Web Accessible Population Pharmacokinetic Service-Hemophilia (WAPPS-Hemo) Tool in Severe Hemophilia Patients Undertaking Personalized Regimen Tailoring | en_US |
| dc.type | Thesis | en_US |
| dc.contributor.department | Health Research Methodology | en_US |
| dc.description.degreetype | Thesis | en_US |
| dc.description.degree | Master of Science (MSc) | en_US |
| Appears in Collections: | Open Access Dissertations and Theses | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Mussa_Final Thesis Paper.pdf | A design pilot study proposed as a Canadian, multicenter, open-label, randomized waitlist clinical trial over the duration of six months to determine the success of running a full-scale RCT with the newly designed WAPPS-Hemo calculator in the Canadian Hemophilia community. The WAPPS-Hemo calculator is widely viewed as a beneficial tool to clinicians and patients and has the potential to optimize and tailor the prophylaxis regimen for hemophilia patients. | 3.89 MB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.
